Positive pre-clinical data has been announced by the pharmaceutical company Reata, providing more support for the rationale to test their drug, omaveloxolone, in neurodegenerative conditions such as Friedreich’s ataxia. Read the press release here. This drug is the same as the one currently in trials around the world including at the London Ataxia Centre. See here for more information about taking part.
Posted on 26/03/2018
Take part in a challenge or create your fundraiser. Every penny you raise will help those affected by ataxia.
To make either a one off or recurring donation which will help fund research into treatments and cures and supports those affected ataxia
Support the ataxia community and volunteer with Ataxia UK. From social media to telephone befriending, there are loads of ways you can make a difference to someone's life.
